Melt-extruded particulate dispersions

Pharmaceutical Extrusion Technology

Volumn , Issue , 2003, Pages 261-276

  Dyar, S Craig ^a   Mollan, Matthew ^a   Ghebre Sellassie, Isaac ^b,c  

^a PFIZER INC   (United States)

^b MEGA Pharmaceuticals   (Eritrea)

^c Pharmaceutical Technology Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76649105581     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (19)

1. Mayersohn M. Principles of drug absorption. In: Banker GS, Rhodes C, eds. Modern Pharmaceutics. Drug and the Pharmaceutical Sciences. Vol. 72. 3rd Ed. New York: Marcel Dekker, 1996:21-73.
2. Fincher JH. Particle size of drugs and its relationship to abstivity. J Pharm Sci 1968; 57:1825-1835.
3. Gould PL. Salt selection for basic drugs. Int J Pharm 1986; 33:201-217.
4. Bekers O, Uijtendaal EV, Beijnen JH, Bult A, Underberg WJM. Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm 1991; 17:1503-1549.
5. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971; 62:1281-1302.
6. Haleblian JK, McCrone W. Pharmaceutical applications of polymorphism. J Pharm Sci 1969; 58:911-929.
7. 2 antisolvent with enhanced mass transfer. Int J Pharm 2001; 228:19-31.
8. Carstensen J. Advanced Pharmaceutical Solids. New York, NY: Marcel Dekker, 2001:314-318.
9. Bagchi P, Scaringe RP, Bosch HW. Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers. U.S. Patent 5,665,331.
10. Lan D. Method of preparing stable drug nanoparticles. U.S. Patent 5,534,270.
11. Wong S. Sugar base surfactant for nanocrystals. U.S. Patent 5,622,938.
12. Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 1995; 125(1):91-97.
13. Hem SL, Feldkamp JR, White JL. Basic chemical principles related to emulsion and suspension dosage forms. In: Lachman L, Lieberman HA, Kanig JL, eds. The Theory and Practice of Industrial Pharmacy, Philadelphia, PA: Lea and Febiger, 1986:116-117.
14. Otsuka M, Kaneniwa N. Effect of grinding on the transformations of polymorphs of chloramphenicol palmitate. Chem Pharm Bull 1985; 33(4):1660-1668.
15. Lee KC, Hersey JA. Crystal modification of methisazone by grinding. J Pharm Pharmacol 1977; 29:249-250.
16. Chiou W-L, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971; 60:1281-1302.
17. Nanda AR, Rowlings CE, Barker NP, Sheen P-C. Immediate release solid dispersions for oral drug delivery. In: Liu R, ed. Water-Insoluble Drug Formulation. Denver, CO: Interpharm Press, 2000:493-523.
18. Grabowski S, Sanner A, Rosenberg J. Compositions which contain active substances and are in the form of solid particles. U.S. Patent 5,641,516.
19. Ghebre-Sellassie I. Solid pharmaceutical dosage forms in form of a particulate dispersion. PCT 9908660.